BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23161620)

  • 1. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
    Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
    Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cheng SC; Cai T; Cagan A; Gainer VS; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1342-8.e1. PubMed ID: 24407106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
    Pierce BL; Neuhouser ML; Wener MH; Bernstein L; Baumgartner RN; Ballard-Barbash R; Gilliland FD; Baumgartner KB; Sorensen B; McTiernan A; Ulrich CM
    Breast Cancer Res Treat; 2009 Mar; 114(1):155-67. PubMed ID: 18401703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory potential of the diet and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
    Jakszyn P; Cayssials V; Buckland G; Perez-Cornago A; Weiderpass E; Boeing H; Bergmann MM; Vulcan A; Ohlsson B; Masala G; Cross AJ; Riboli E; Ricceri F; Dahm CC; Nyvang D; Katzke VA; Kühn T; Kyrø C; Tjønneland A; Ward HA; Tsilidis KK; Skeie G; Sieri S; Sanchez MJ; Huerta JM; Amiano P; Lasheras C; Ardanaz E; Mahamat-Saleh Y; Boutron-Ruault MC; Carbonnel F; Panico S; Peppa E; Trichopoulou A; Karakatsani A; Tumino R; Vermeulen R; Jenab M; Gunter M; Agudo A
    Int J Cancer; 2020 Aug; 147(4):1027-1039. PubMed ID: 31945199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts.
    Gwenzi T; Schrotz-King P; Anker SC; Schöttker B; Hoffmeister M; Brenner H
    ESMO Open; 2024 Apr; 9(4):102982. PubMed ID: 38613909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations.
    Nimptsch K; Aleksandrova K; Fedirko V; Jenab M; Gunter MJ; Siersema PD; Wu K; Katzke V; Kaaks R; Panico S; Palli D; May AM; Sieri S; Bueno-de-Mesquita B; Standahl K; Sánchez MJ; Perez-Cornago A; Olsen A; Tjønneland A; Bonet CB; Dahm CC; Chirlaque MD; Fiano V; Tumino R; Gurrea AB; Boutron-Ruault MC; Menegaux F; Severi G; van Guelpen B; Lee YA; Pischon T
    BMC Cancer; 2022 Jun; 22(1):695. PubMed ID: 35739525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
    Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.
    Aleksandrova K; Chuang SC; Boeing H; Zuo H; Tell GS; Pischon T; Jenab M; Bueno-de-Mesquita B; Vollset SE; Midttun Ø; Ueland PM; Fedirko V; Johansson M; Weiderpass E; Severi G; Racine A; Boutron-Ruault MC; Kaaks R; Kühn T; Tjønneland A; Overvad K; Quirós JR; Jakszyn P; Sánchez MJ; Dorronsoro M; Chirlaque MD; Ardanaz E; Khaw KT; Wareham NJ; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Panico S; May AM; Palmqvist R; Ljuslinder I; Kong SY; Freisling H; Gunter MJ; Lu Y; Cross AJ; Riboli E; Vineis P
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25713165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of tobacco smoking and colorectal cancer risk.
    Cross AJ; Boca S; Freedman ND; Caporaso NE; Huang WY; Sinha R; Sampson JN; Moore SC
    Carcinogenesis; 2014 Jul; 35(7):1516-22. PubMed ID: 24648381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer.
    Zajkowska M; Dulewicz M; Kulczyńska-Przybik A; Safiejko K; Juchimiuk M; Konopko M; Kozłowski L; Mroczko B
    Sci Rep; 2023 Oct; 13(1):17688. PubMed ID: 37848726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.
    Chen W; Wang JB; Abnet CC; Dawsey SM; Fan JH; Yin LY; Yin J; Taylor PR; Qiao YL; Freedman ND
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):386-92. PubMed ID: 25613115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial analysis of blood biomarker concentrations in dogs with pneumonia, septic peritonitis, and pyometra.
    Goggs R; Robbins SN; LaLonde-Paul DM; Menard JM
    J Vet Intern Med; 2022 Mar; 36(2):549-564. PubMed ID: 35103342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein is more suitable than Serum Amyloid A to monitor crises and attack-free periods in Systemic Auto-Inflammatory Diseases.
    Parentelli AS; Lopes AA; Fellahi S; Savey L; Bastard JP; Georgin-Lavialle S
    Eur J Intern Med; 2024 May; ():. PubMed ID: 38724309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
    Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
    Bever AM; Hang D; Lee DH; Tabung FK; Ugai T; Ogino S; Meyerhardt JA; Chan AT; Eliassen AH; Liang L; Stampfer MJ; Song M
    J Natl Cancer Inst; 2024 Mar; ():. PubMed ID: 38430005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Inflammatory and Oxidative Stress Biomarkers and Plasma Metabolites in a Longitudinal Study of Healthy Male Welders.
    Gao S; Quick C; Guasch-Ferre M; Zhuo Z; Hutchinson JM; Su L; Hu F; Lin X; Christiani D
    J Inflamm Res; 2021; 14():2825-2839. PubMed ID: 34234508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and Gut Barrier Function-Related Genes and Colorectal Cancer Risk in Western European Populations.
    Mandle HB; Jenab M; Gunter MJ; Tjønneland A; Olsen A; Dahm CC; Zhang J; Sugier PE; Rothwell J; Severi G; Kaaks R; Katzke VA; Schulze MB; Masala G; Sieri S; Panico S; Sacerdote C; Bonet C; Sánchez MJ; Amiano P; Huerta JM; Guevara M; Palmqvist R; Löwenmark T; Perez-Cornago A; Weiderpass E; Heath AK; Cross AJ; Vineis P; Hughes DJ; Fedirko V
    Mutagenesis; 2024 Mar; ():. PubMed ID: 38441165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Aleksandrova K; Jenab M; Bueno-de-Mesquita HB; Fedirko V; Kaaks R; Lukanova A; van Duijnhoven FJ; Jansen E; Rinaldi S; Romieu I; Ferrari P; Murphy N; Gunter MJ; Riboli E; Westhpal S; Overvad K; Tjønneland A; Halkjær J; Boutron-Ruault MC; Dossus L; Racine A; Trichopoulou A; Bamia C; Orfanos P; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Peeters PH; Duell EJ; Molina-Montes E; Quirós JR; Dorronsoro M; Chirlaque MD; Barricarte A; Ljuslinder I; Palmqvist R; Travis RC; Khaw KT; Wareham N; Pischon T; Boeing H
    Eur J Epidemiol; 2014 Apr; 29(4):261-75. PubMed ID: 24791703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.
    Bae S; Ulrich CM; Neuhouser ML; Malysheva O; Bailey LB; Xiao L; Brown EC; Cushing-Haugen KL; Zheng Y; Cheng TY; Miller JW; Green R; Lane DS; Beresford SA; Caudill MA
    Cancer Res; 2014 Dec; 74(24):7442-52. PubMed ID: 25336191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort.
    Miller JW; Beresford SA; Neuhouser ML; Cheng TY; Song X; Brown EC; Zheng Y; Rodriguez B; Green R; Ulrich CM
    Am J Clin Nutr; 2013 Apr; 97(4):827-34. PubMed ID: 23426034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.